DVA Stock Analysis: Buy, Sell, or Hold?
DVA - DaVita Inc.
$152.80
-1.63 (-1.06%)
▼
5d:
+0.39%
30d:
-2.24%
90d:
+34.06%
BUY
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Distribution
DVA is up 4.4% this week, but smart money is buying puts. Top strike: $145 2026-05-15 with 1 OI. Put ratio: 100% View Scanner →
Strength: 7.2/10
Get Alerted When DVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DVA shows positive signals but monitor for confirmation. Market pricing in 1.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: DVA shows positive signals but monitor for confirmation. Market pricing in 1.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$238.47
Based on 10.0% avg growth
INTRINSIC VALUE TODAY
$148.07
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DVA is currently trading at $152.80, which is considered fair relative to its 30-day fair value range of $149.53 to $154.31. The stock's valuation (Forward PE: 9.5) is in line with its historical norms (9.1). At these levels, the market is pricing in 1.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DVA is in a strong uptrend. The price is currently testing key support at $148.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DVA is in a strong uptrend. The price is currently testing key support at $148.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$149.53 -
$154.31
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($151.71)
- NEUTRAL: Market pricing in 1.4% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$149.53 -
$154.31
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$8.68
(5.7%)
Support & Resistance Levels
Support Level
$148.81
Resistance Level
$157.18
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.46
Wall Street Target
$151.71
(-1.8%)
Revenue Growth (YoY)
9.9%
Earnings Growth (YoY)
6.5%
Profit Margin
5.5%
Valuation Premium vs History
+1.4% premium
PE vs Historical
9.5 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.4%
(market-implied from PE analysis)
1-Year Target
$156.59
(+1%)
2-Year Target
$158.78
(+3%)
3-Year Target
$161.01
(+4%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$154.95
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 16.0%)
$570.55
(+270%)
Base:
(SPY PE: 9.5, Growth: 16.0%)
$240.84
(+56%)
Bear:
(PE: 8.0, Growth: 16.0%)
$204.72
(+33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 15.70 | Current EPS (TTM): $9.51
Bull Case
$282.06
(+85%)
Analyst growth 71.7%, PE expands to 17.3
Base Case
$256.42
(+69%)
Market implied 71.7%, PE stable at 15.7
Bear Case
$101.53
(-33%)
Severe decline -20.0%, PE contracts to 13.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 30, 2026 1:33 PM ET
Data refreshes hourly during market hours. Next update: 2:33 PM
Data refreshes hourly during market hours. Next update: 2:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
DVA is a key holding in these high-performance investment strategies.
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 60 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
UHS
Universal Health Service… |
HOLD
19 analysts |
$249 | 60 HOLD |
Advanced DVA Option Strategies
Professional options setups generated by AI based on today's DVA price and gamma walls.
